Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcabene in HoFH (COBALT-1)
NCT02722408Phase 2Completed
- Sponsor
- NeuroBo Pharmaceuticals
- Start
- Jun 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, open-label, single-arm trial of gemcabene in homozygous familial hypercholesterolemia (HoFH), sponsored by NeuroBo Pharmaceuticals. Primary endpoint: Percent Change From Baseline in LDL-C at Day 84. Started Jun 2016; status: completed.
02
Drugs
gemcabene
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT02722408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02722408.